Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Adeniji-Popoola O
Ametantrone is the second anthracene derivative to enter clinical trials
Chemical Name: 4-{ethyl[1-(4-methoxyphenyl)propan-2-yl]amino}butan-1-ol
InChiKey: YBGGBHCJSAEIAS-UHFFFAOYSA-N
Palbociclib 1150 Adeniji-Popoola OPalbociclib, also known as PD 0332991, is an orally available cyclin dependent kinase (CDK) inhibitor with potential antineoplastic activity. Palbociclib selectively inhibits cyclin dependent kinase 4 (CDK4) and 6 (CDK6), thereby inhibiting retinoblastoma (Rb) protein phosphorylation early in the G1 phase leading to cell cycle arrest. This suppresses DNA replication and decreases tumor cell proliferation. CDK4 and 6 are serine threonine kinases that
US$ 134.50
US$ 199.50
US$ 124.50
US$ 134.50